Different molecular factors such as p53 mutation, Ki-67/MIB-1 labeling index, and O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation have been correlated with GBM recurrences [48,49]. Here, MGMT is linked to glioblastoma.